Metabolomic profile and bioactivity of fungal endophytes isolated from Crinum macowanii.

BACKGROUND

Crinum macowanii is a therapeutic plant acknowledged for its rich phytochemical profile and traditional medicinal uses. Research on endophytic fungi has surged due to their ability to produce bioactive secondary metabolites, many of which have antimicrobial and antiproliferative or cytotoxic properties. This study evaluated the diversity, antimicrobial and antiproliferative potential, and metabolomic profiles of fungal endophytes isolated from C. macowanii.

RESULTS

Fungal endophytes were isolated from fresh leaves and bulbs of C. macowanii collected from a botanical garden. The endophytes were identified using cultural and molecular techniques, and sequences were deposited in GenBank. Crude secondary metabolites were extracted from the fungal endophytes by fermentation, and the antibacterial activity and minimum inhibitory concentration (MIC) of the extracts were evaluated using a 96-well plate Resazurin Microtiter assay. Cytotoxicity assays were carried out using U87MG Glioblastoma cells and A549 Lung carcinoma cell lines to assess the antiproliferative effect of the secondary metabolites. An untargeted analysis of the bioactive components from two endophytes with the most active antibacterial metabolites was conducted using LC-Q-TOF-MS. The results revealed that six fungal endophytes (Filobasidium magnum, Filobasidium sp., Alternaria alternata, A. tenuissima, Penicillium sp., and P. chrysogenum) were identified from the leaves and bulb of C. macowanii. There was significant antibacterial activity, specifically from Penicillium sp., against several pathogens of public health importance. Cytotoxicity assessments on A549 lung carcinoma and UMG87 glioblastoma cell lines showed mild cytotoxicity compared to the auranofin control, with 87.13% cell viability at 100 µg/mL on A549 cells. LC-Q-TOF-MS analysis identified eight secondary metabolites. Four were shared between A. tenuissima and Penicillium sp., while each species produced two unique compounds. The high efficacy of some of the extracts from these endophytes against clinically relevant pathogens underscores their relevance to public health, especially in combating infectious diseases where traditional antibiotics could have been ineffective.

CONCLUSION

This study emphasizes the importance of endophytes in drug discovery, particularly in contexts where resistance to conventional treatments is rising. With AMR at critical levels, endophytes like Penicillium species offer leads for next-generation antibiotics to overcome pathogen resistance. The selective antiproliferative potential of the crude extract warrants further investigation, as it could pave the way for developing novel, targeted anticancer therapies with potentially fewer side effects.

CLINICAL TRIAL NUMBER

Not applicable.